7783-35-9 1차 2020-08-25
8.00257.0100 800257 3-CHLORO-1-PROPENE (STABILISED WITH PROP 107-05-1 1차 2020-08-25
8.00257.1000 800257 3-CHLORO-1-PROPENE (STABILISED WITH PROP 107-05-1 1차
트리부틸아민[Tributylamine; 102-82-9] 및 이를 25% 이상 함유한 혼합물질 급성 흡입독성
2019-20 에피클로로히드린[Epichlorohydrin; 106-89-8] 및 이를 0.1% 이상 함유한 혼합물질
급성 흡입독성,
인화성 액체
2019-21 아크롤레인[Acrolein; 107-02-8] 및 이를 1.0% 이상 함유한 혼합물질
Z., et al., Cell, 87, 1327-1338 (1996).
7. McHugh, T. J., et al., Cell, 87, 1339-1349 (1996).
8. Advokat, C. and Pellegrin, A. I., Neurosci.
Biobehav. Rev., 16, 13-24 (1992).
9. Beal, M. F., FASEB
Z., et al., Cell, 87, 1327-1338 (1996).
7. McHugh, T. J., et al., Cell, 87, 1339-1349 (1996).
8. Advokat, C. and Pellegrin, A. I., Neurosci.
Biobehav. Rev., 16, 13-24 (1992).
9. Beal, M. F., FASEB
Z., et al., Cell, 87, 1327-1338 (1996).
7. McHugh, T. J., et al., Cell, 87, 1339-1349 (1996).
8. Advokat, C. and Pellegrin, A. I., Neurosci.
Biobehav. Rev., 16, 13-24 (1992).
9. Beal, M. F., FASEB
Z., et al., Cell, 87, 1327-1338 (1996).
7. McHugh, T. J., et al., Cell, 87, 1339-1349 (1996).
8. Advokat, C. and Pellegrin, A. I., Neurosci.
Biobehav. Rev., 16, 13-24 (1992).
9. Beal, M. F., FASEB
compliance with EMA/410/01 rev.3.
USP 87> Biological
Reactivity Tests Component materials were tested and meet the criteria for non-cytotoxicity for the USP 87> Cytoxicity MEM Elution Tests.
USP <
of the lactone plus
carboxylate forms, in human plasma. J.
Chromatogr. B. Biomed. Appl., 668(1), 107-115
(1995).
GCY/RXR 5/03
Sigma brand products are sold through Sigma-Aldrich, Inc.
determined by the Limulus Amebocyte Lysate (LAL)
Test.
Bacterial Retention Quantitative retention of 107 CFU/cm2 Brevundimonas diminuta ATCC® 19146 per ASTM® F838
methodology
Sterilization May be autoclaved
I., Proc. Natl. Acad.
Sci. USA, 87, 9113-9117 (1990).
6. Spiegel, A. M., Mol. Cell Endocrinol., 49, 1-16,
(1987).
7. de Almeida, et al., J. Cell Sci., 107, 507-515 (1994).
8. Wilkie, T. M.
Acad.
Sci. USA, 87, 9113-9117 (1990).
7. Wilkie, T. M., and Yokoyama, K. S., Soc. Gen.
Physiol. Ser., 49, 249-270 (1994).
8. Chen, C., et al., Am. J. Physiol., 275, E278 (1998).
9. Watling, K.J.
appropriate amount of cell lysis
(RIPA) buffer.
o For example, for the extraction of
106 – 107 cells, or of 5-20 mg tissue,
prepare 1 mL of cell lysis buffer, such
as follows:
15955
(1991).
8. Strathmann, M., and Simon, M. I., Proc. Natl. Acad.
Sci. USA, 87, 9113-9117 (1990).
9. Wilkie, T. M., and Yokoyama, K. S., Soc. Gen.
Physiol. Ser., 49, 249-270 (1994).
10
Sci. USA, 87, 9113-9117 (1990).
7. Wilkie, T. M., and Yokoyama, K. S., Soc. Gen.
Physiol. Ser., 49, 249-270 (1994).
8. Spiegel, A. M. Mol. Cell Endocrinol., 49, 1-16
(1987).
9. The RBI Handbook
Sci. USA, 87, 9113-9117 (1990).
7. Wilkie, T. M. and Yokoyama, K. S. Soc. Gen.
Physiol. Ser., 49, 249-270 (1994).
8. Spiegel, A. M. Mol. Cell Endocrinol., 49, 1-16
(1987).
9. Roos, W. et
I., Proc. Natl. Acad.
Sci. USA, 87, 9113-9117 (1990).
6. Spiegel, A. M., Mol. Cell Endocrinol., 49, 1-16,
(1987).
7. de Almeida et al., J. Cell Sci., 107, 507-515 (1994).
8. Wilkie, T. M., and